Synairgen (LSE:SNG) Interest Income : £0.58 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Synairgen Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Synairgen's interest income for the six months ended in Jun. 2024 was £0.24 Mil. Its interest income for the trailing twelve months (TTM) ended in Jun. 2024 was £0.58 Mil.

Synairgen Interest Income Historical Data

The historical data trend for Synairgen's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synairgen Interest Income Chart

Synairgen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Income

Get a 7-Day Free Trial

0.03

0.02

0.01

0.21

0.64

Synairgen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Income	Get a 7-Day Free Trial															0.02	0.18	0.30	0.34	0.24

Synairgen Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.58 Mil.

Synairgen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (LSE:SNG) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

SYGGF:USA OMY:Germany

Address

Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD

Website

https://www.synairgen.com

Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.

Synairgen Headlines

No Headlines